Cargando…
Circulating biosignatures in multiple myeloma and their role in multidrug resistance
A major obstacle to chemotherapeutic success in cancer treatment is the development of drug resistance. This occurs when a tumour fails to reduce in size after treatment or when there is clinical relapse after an initial positive response to treatment. A unique and serious type of resistance is mult...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148481/ https://www.ncbi.nlm.nih.gov/pubmed/37120508 http://dx.doi.org/10.1186/s12943-022-01683-w |